Does fluoxetine reverse the effects of early life stress on the CNS corticotropin-releasing factor system and improve psychological and neuroendocrine function?: a therapy outcome study in women with childhood abuse experiences
Phase of Trial: Phase II
Latest Information Update: 08 Nov 2013
At a glance
- Drugs Fluoxetine (Primary)
- Indications Major depressive disorder
- Focus Pharmacodynamics
- 31 Aug 2018 Biomarkers information updated
- 08 Apr 2009 Actual end date (November 2007) added as reported by ClinicalTrials.gov.
- 08 Apr 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.